Cytotoxic activities of [Ser⁴⁹]phospholipase A₂ from the venom of the saw-scaled vipers Echis ocellatus, Echis pyramidum leakeyi, Echis carinatus sochureki, and Echis coloratus

Toxicon. 2013 Sep:71:96-104. doi: 10.1016/j.toxicon.2013.05.017. Epub 2013 Jun 4.

Abstract

Fractionation by reversed-phase HPLC of venom from four species of saw-scaled viper: Echis ocellatus, Echis pyramidum leakeyi, Echis carinatus sochureki, and Echis coloratus led to identification in each sample of an abundant protein with cytotoxic activity against human non-small cell lung adenocarcinoma A549 cells. The active component in each case was identified by MALDI-TOF mass fingerprinting of tryptic digests as [Ser⁴⁹]phospholipase A₂ ([Ser⁴⁹]PLA₂). An isoform of [Ser⁴⁹]PLA₂ containing the single Ala¹⁸→ Val substitution and a partially characterized [Asp⁴⁹]PLA₂ were also present in the E. coloratus venom. LC₅₀ values against A549 cells for the purified [Ser⁴⁹]PLA₂ proteins from the four species are in the range 2.9-8.5 μM. This range is not significantly different from the range of LC₅₀ values against human umbilical vein endothelial HUVEC cells (2.5-12.2 μM) indicating that the [Ser⁴⁹]PLA₂ proteins show no differential anti-tumor activity. The LC₅₀ value for [Ser⁴⁹]PLA₂ from E. ocellatus against human erythrocytes is >100 μM and the MIC values against Escherichia coli and Staphylococcus aureus are >100 μM. It is suggested that the [Ser⁴⁹]PLA₂ proteins play a major role in producing local tissue necrosis and hemorrhage at the site of envenomation.

Keywords: Adenocarcinoma A549 cells; Anti-cancer activity; Cytotoxicity; Echis; Human umbilical vein endothelial cells; Phospholipase A(2).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Antineoplastic Agents / pharmacology*
  • Chromatography, High Pressure Liquid
  • Erythrocytes / drug effects
  • Erythrocytes / metabolism
  • Escherichia coli / drug effects
  • Escherichia coli / growth & development
  • Human Umbilical Vein Endothelial Cells / drug effects
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Humans
  • Inhibitory Concentration 50
  • Molecular Sequence Data
  • Phospholipases A2 / isolation & purification
  • Phospholipases A2 / pharmacology*
  • Snake Bites / pathology
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / growth & development
  • Viper Venoms / pharmacology*
  • Viperidae* / classification

Substances

  • Anti-Bacterial Agents
  • Antineoplastic Agents
  • Viper Venoms
  • Phospholipases A2